Skip to main content
OpenTrials
Completed

NCT Number: NCT01996553

The Prevalence of Radial Artery Occlusion in Diagnostic Cardiac Catheterization and Percutaneous Intervention

The purpose of this study is to establish the rate of radial artery occlusion post transradial cardiac catheterization through different modalities.

The study hypothesis is that specialized imaging can provide specific information to help identify hand complications after cardiac catheterization through the wrist.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Coronary Angiography Arterial Occlusive Diseases Cardiovascular Diseases Radial Artery Occlusion Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Jesse Brown VA Medical Center

Chicago, Illinois, 60612, United States

About this study

The purpose of this study is to establish the rate of radial artery occlusion post diagnostic/interventional cardiac catheterization through different modalities, and to compare current assessment methods (such as Allen's test, Modified Barbeau test and duplex ultrasonography) to specialized imaging techniques for sensitivity and specificity of radial artery occlusion detection post transradial catheterization.

The study hypothesis is that specialized imaging can provide a specific focused analysis of hand characteristics to identify physiologic abnormalities as a result of radial artery occlusion post transradial catheterization.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult subjects over the age of 18 who present to the Jesse Brown VA cath lab for a diagnostic radial artery angiogram or percutaneous intervention will be considered for the study.

Exclusion criteria

  • Any subject who is unable to give informed consent or declines to participate will be excluded.
  • Patients who have previously had a cardiac catheterization through the radial artery will be excluded because it will not be known if the changes to the circulation of the hand is secondary to the current or previous transradial catheterization.

Treatment and study plan

Primary outcomes

  1. Physiologic abnormalities of the hand

    Time frame: 1 day to 3 weeks post transradial cardiac catheterization

    Blood flow to the hand in which transradial access was accomplished will be assessed for physiologic abnormalities as a result of radial artery occlusion post transradial catheterization

  2. Physiologic abnormalities of the hand

    Time frame: 3 weeks to 3 months post transradial cardiac catheterization

    Blood flow to the hand in which transradial access was accomplished will be assessed for physiologic abnormalities as a result of radial artery occlusion

Secondary outcomes

  1. Radial Artery Occlusion

    Time frame: 1 day to 3 weeks post transradial catheterization

    Radial artery blood flow will be assessed for patency or occlusion 1 day to 3 weeks post transradial cardiac catheterization

  2. Radial Artery Occlusion

    Time frame: 3 weeks to 3 months post transradial catheterization

    Radial artery blood flow will be assessed for patency or occlusion 3 weeks to 3 months post transradial catheterization

Sponsors and collaborators

Lead sponsor

Jesse Brown VA Medical Center

Fed

Registry information

Important dates

Study start
2013
Primary completion
2017
Study completion
2017
First posted
Nov 27, 2013
Registry last updated
Aug 9, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.